Evidence map›Paper›PMID 25364499›Full record

ReviewCell & bioscience2014

Strategies for gene disruption in Drosophila.

Shih-Ching Lin, Yu-Yun Chang, Chih-Chiang Chan

Abstract readReview
In one paragraph

Review in Cell & bioscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Naming CRISPR alleles: endonuclease-mediated mutation nomenclature across species.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Mechanisms of gene targeting in higher eukaryotes.Cellular and molecular life sciences : CMLS · 2016
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shih-Ching LinGraduate Institute of Physiology, National Taiwan University, No.1, Sec. 1, Jen-Ai Rd., Zhongzheng Dist, Taipei, 100 Taiwan.
Yu-Yun ChangGraduate Institute of Molecular Medicine, National Taiwan University, No.1, Sec. 1, Jen-Ai Rd., Zhongzheng Dist, Taipei, 100 Taiwan.
Chih-Chiang ChanGraduate Institute of Physiology, National Taiwan University, No.1, Sec. 1, Jen-Ai Rd., Zhongzheng Dist, Taipei, 100 Taiwan ; Graduate Institute of Brain and Mind Sciences, National Taiwan University, No.1, Sec. 1, Jen-Ai Rd., Zhongzheng Dist, Taipei, 100 Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drosophila melanogaster has been a classic model organism for the studies of genetics. More than 15,000 Drosophila genes have been annotated since the entire genome was sequenced; however, many of them still lack functional characterization. Various gene-manipulating approaches in Drosophila have been developed for the function analysis of genes. Here, we summarize some representative strategies utilized for Drosophila gene targeting, from the unbiased ethyl methanesulfonate (EMS) mutagenesis and transposable element insertion, to insertional/replacement homologous recombination and site-specific nucleases such as the zinc-finger nuclease (ZFN), the transcription activator-like effector nuclease (TALEN) and the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system. Specifically, we evaluate the pros and cons of each technique in a historical perspective. This review discuss important factors that should be taken into consideration for the selection of a strategy that best fits the specific needs of a gene knockout project.

Indexed as

Cas9CRISPRDrosophilaGene knock-outGenome editingHomologous recombinationTransposons

Identifiers

PMID25364499
PMCPMC4216337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.